VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ARVN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ARVNArvinas, Inc.
$6.82$440M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksARVNFinancials

Arvinas, Inc. (ARVN) Income Statement

10Y historyFree accessUpdated daily

Revenue and margins have been highly volatile, with gross margin ranging from 80.0% to 100.0% but operating margin swinging from 65.7% in 2026Q2 to -118.2% in 2026Q3, indicating that profitability depends on lumpy collaboration recognition rather than a stable operating base.

Income StatementBalance SheetCash FlowRatios

ARVN Income Statement

Annual statement

ARVN Income Statement

Arvinas, Inc. (ARVN) annual income statement — 10-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16
Sales/Revenue275.3M262.6M263.4M78.5M131.4M53.6M25.9M42.98M14.32M7.58M6.67M
Revenue Growth %-11.85%-0.3%235.54%-40.26%145.15%106.95%-39.73%200.03%89%13.64%-
Cost of Goods Sold11.4M5.2M000000000
COGS % of Revenue-1.98%---------
Gross Profit263.9M257.4M263.4M78.5M131.4M53.6M25.9M42.98M14.32M7.58M6.67M
Gross Margin %95.86%98.02%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %--2.28%235.54%-40.26%145.15%106.95%-39.73%200.03%89%13.64%-
Operating Expenses293.3M372.3M513.6M480M394.6M242M146.7M94.5M58.13M32.34M23.14M
OpEx % of Revenue-141.77%194.99%611.47%300.3%451.49%566.41%219.89%405.8%426.7%346.95%
Selling, General & Admin76.2M89.4M165.4M100.3M79.6M61.6M38.3M27.31M12.93M3.55M3.2M
SG&A % of Revenue-34.04%62.79%127.77%60.58%114.93%147.88%63.54%90.28%46.79%47.93%
Research & Development220.6M282.9M348.2M379.7M315M180.4M108.4M67.19M45.19M28.79M19.94M
R&D % of Revenue-107.73%132.19%483.69%239.73%336.57%418.53%156.35%315.51%379.91%299.03%
Other Operating Expenses-1000K0000000102.73K00
Operating Income-29.4M-114.9M-250.2M-401.5M-263.2M-188.4M-120.8M-51.52M-43.8M-24.76M-16.47M
Operating Margin %-10.68%-43.75%-94.99%-511.47%-200.3%-351.49%-466.41%-119.89%-305.8%-326.7%-246.95%
Operating Income Growth %-54.08%37.68%-52.55%-39.7%-55.96%-134.45%-17.63%-76.9%-50.34%-
EBITDA-25.9M-109.7M-243.6M-394.8M-255M-182.4M-116.7M-49.27M-43.1M-24.41M-16.03M
EBITDA Margin %-9.41%-41.77%-92.48%-502.93%-194.06%-340.3%-450.58%-114.65%-300.87%-322.12%-240.41%
EBITDA Growth %73.16%54.97%38.3%-54.82%-39.8%-56.3%-136.85%-14.33%-76.53%-52.27%-
D&A (Non-Cash Add-back)3.5M5.2M6.6M6.7M8.2M6M4.1M2.25M706K347.39K436.33K
EBIT-25.2M-80.5M-198.3M-366.4M-261.6M-190.9M-120.8M-70.21M-41.42M-24M-14.37M
Net Interest Income26.3M22M54.8M38.8M12M1.7M3.52M4.5M2.41M151.03K360.37K
Interest Income26.3M22M54.8M38.8M12M1.8M3.59M4.6M2.47M201.39K427.77K
Interest Expense00000100K65K100K57.44K50.36K67.4K
Other Income/Expense20.6M34.4M51.9M35.1M1.6M-2.6M1.5M-18.79M2.32M711.06K2.03M
Pretax Income-8.8M-80.5M-198.3M-366.4M-261.6M-191M-119.3M-70.3M-41.48M-24.05M-14.44M
Pretax Margin %-3.2%-30.65%-75.28%-466.75%-199.09%-356.34%-460.62%-163.58%-289.59%-317.32%-216.49%
Income Tax300K300K600K900K20.9M00000-87.41K
Effective Tax Rate %-3.41%-0.37%-0.3%-0.25%-7.99%0%0%0%0%0%0.61%
Net Income-9.5M-80.8M-198.9M-367.3M-282.5M-191M-119.3M-70.29M-41.48M-24.05M-14.35M
Net Margin %-3.45%-30.77%-75.51%-467.9%-214.99%-356.34%-460.62%-163.56%-289.59%-317.32%-215.18%
Net Income Growth %83.76%59.38%45.85%-30.02%-47.91%-60.1%-69.72%-69.46%-72.48%-67.58%-
Net Income (Continuing)-9.1M-80.8M-198.9M-367.3M-282.5M-191M-119.3M-70.3M-41.48M-24.05M-14.35M
Discontinued Operations00000000000
Minority Interest00000000000
EPS (Diluted)-0.15-1.28-2.77-6.62-5.31-3.82-3.02-1.89-1.31-1.38-7.56
EPS Growth %77.78%53.79%58.16%-24.67%-39.01%-26.49%-59.79%-44.27%5.07%81.75%-
EPS (Basic)--1.28-2.77-6.62-5.31-3.82-3.02-1.89-1.31-1.38-7.56
Diluted Shares Outstanding65.4M64.9M71.9M55.5M53.2M50M39.53M32.93M31.63M20.73M1.9M
Basic Shares Outstanding65.4M64.9M71.9M55.5M53.2M50M39.53M32.93M31.63M20.73M1.9M
Dividend Payout Ratio-----------

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Lumpy collaboration revenue dependence

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Driven by Lumpy Collaboration Milestones

Based on reported quarterly figures, ARVN revenue swung from $249.7M in 2026Q2 to just $0.5M in 2026Q3, a pattern that signals revenue recognition tied to episodic partnership events rather than recurring demand.

The quarterly series shows no sustained compounding; instead, revenue alternates between large milestone-driven spikes and near-zero quarters. This suggests growth durability is low and that trailing comparisons carry little predictive value. Investors should monitor whether future collaboration milestones reappear at similar scale before extrapolating any trend.

Operating Losses Persist Despite Revenue Peaks

According to reported income statements, R&D expense has remained between roughly $47M and $91M per quarter, and operating income has been negative in most periods, indicating limited operating leverage.

Operating income turns positive only in quarters with outsized revenue, such as 2026Q2 at $164.1M, while the cost base stays largely fixed. This implies that operating results are dominated by the timing of licensing receipts rather than by scalable operating efficiency. The shortfall in operating leverage warrants further investigation into the durability of the cost structure.

Net Income Dependent on Non-Operating Swings

Reported net income tracks operating income closely, but EPS swung from $2.58 in 2026Q2 to -$0.90 in 2026Q1, showing that per-share results remain highly volatile.

Because net income moves in step with lumpy revenue, the quality of reported earnings depends heavily on the recognition timing of partnership payments. Stock-based compensation remains material relative to quarterly operating costs, at $5.9M to $24.7M per quarter, which reduces the economic residual available to shareholders. Investors should treat single-quarter profitability as non-representative.

Cost Base Stable While Revenue Fluctuates

Based on EDBL-style cost reporting, ARVN's R&D spending of $46.9M to $93.7M per quarter has remained the dominant expense, while SG&A has ranged from $12.6M to $75.8M.

R&D accounts for the majority of the cost base in nearly every period, which is consistent with a clinical-stage development model. The SG&A line has been volatile, with a notable spike in 2024Q3, which may reflect non-recurring items, though this cannot be confirmed from the data provided. The absence of a clear downward trend in R&D suggests continued pipeline investment that weighs on near-term margins.

Peak Quarter May Not Reflect Run-Rate

The strongest bear case is that 2026Q2's $249.7M revenue and $164.1M operating income are non-recurring, and that the surrounding quarters show a business still losing money.

Excluding the 2026Q2 spike, ARVN reported operating losses in the majority of the ten quarters shown, and the most recent quarter registered a loss of $59.1M on only $0.5M of revenue. Short-sellers would likely argue that reported profitability reflects one-time licensing income rather than a sustainable commercial model. This interpretation is inferential and should be weighed against any disclosed upcoming milestone or partnership pipeline.

ARVN — Frequently Asked Questions

Quick answers to the most common questions about buying ARVN stock.

What was Arvinas, Inc.'s (ARVN) revenue in 2025?

For fiscal year 2025, Arvinas, Inc. (ARVN) reported total revenue of $262.6M. This represents a 3837.6% increase compared to $6.7M in 2016.

Is Arvinas, Inc. (ARVN) profitable?

Arvinas, Inc. (ARVN) reported a net loss of $80.8M for the fiscal year ending 2025.

What is Arvinas, Inc.'s operating profit margin?

Arvinas, Inc. (ARVN) reported an operating income of $-114.9M, resulting in an operating profit margin of -43.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Arvinas, Inc.'s gross profit and gross margin?

Arvinas, Inc. (ARVN) generated $257.4M in gross profit for the year, representing a gross profit margin of 98.0%. This demonstrates the company's core pricing power and production efficiency.